Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 95

1.

Amyloid PET, FDG-PET or MRI? - the power of different imaging biomarkers to detect progression of early Alzheimer's disease.

Ortner M, Drost R, Heddderich D, Goldhardt O, Müller-Sarnowski F, Diehl-Schmid J, Förstl H, Yakushev I, Grimmer T.

BMC Neurol. 2019 Oct 31;19(1):264. doi: 10.1186/s12883-019-1498-9.

2.

How a four-year-old boy connects healthcare, biomedical research and undergraduate education.

Drost RH, Dictus WJAG, Prakken BJ, Bovenschen N.

Nat Biotechnol. 2019 Sep;37(9):1092-1095. doi: 10.1038/s41587-019-0245-5. No abstract available.

PMID:
31485047
3.

Cognitive and affective theory of mind in Korsakoff's syndrome.

Drost R, Postma A, Oudman E.

Acta Neuropsychiatr. 2018 Dec 18:1-7. doi: 10.1017/neu.2018.35. [Epub ahead of print]

PMID:
30558689
4.

Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice.

Pajic M, Blatter S, Guyader C, Gonggrijp M, Kersbergen A, Küçükosmanoğlu A, Sol W, Drost R, Jonkers J, Borst P, Rottenberg S.

Clin Cancer Res. 2017 Nov 15;23(22):7020-7033. doi: 10.1158/1078-0432.CCR-17-1279. Epub 2017 Aug 18.

5.

CONCEPTUALIZATIONS OF THE SOCIETAL PERSPECTIVE WITHIN ECONOMIC EVALUATIONS: A SYSTEMATIC REVIEW.

Drost RMWA, van der Putten IM, Ruwaard D, Evers SMAA, Paulus ATG.

Int J Technol Assess Health Care. 2017 Jan;33(2):251-260. doi: 10.1017/S0266462317000526. Epub 2017 Jun 23. Review.

PMID:
28641592
6.

Health-Related Resource-Use Measurement Instruments for Intersectoral Costs and Benefits in the Education and Criminal Justice Sectors.

Mayer S, Paulus ATG, Łaszewska A, Simon J, Drost RMWA, Ruwaard D, Evers SMAA.

Pharmacoeconomics. 2017 Sep;35(9):895-908. doi: 10.1007/s40273-017-0522-4. Review.

7.

Inhomogeneous Poisson process rate function inference from dead-time limited observations.

Verma G, Drost RJ.

J Opt Soc Am A Opt Image Sci Vis. 2017 May 1;34(5):770-782. doi: 10.1364/JOSAA.34.000770.

PMID:
28463321
8.

[Inter-sectoral costs and benefits arising from mental health (disorders)].

Paulus AT, Drost RM, Ruwaard D, Evers SM.

Tijdschr Psychiatr. 2016;58(10):688-694. Dutch.

9.

BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.

Drost R, Dhillon KK, van der Gulden H, van der Heijden I, Brandsma I, Cruz C, Chondronasiou D, Castroviejo-Bermejo M, Boon U, Schut E, van der Burg E, Wientjens E, Pieterse M, Klijn C, Klarenbeek S, Loayza-Puch F, Elkon R, van Deemter L, Rottenberg S, van de Ven M, Dekkers DH, Demmers JA, van Gent DC, Agami R, Balmaña J, Serra V, Taniguchi T, Bouwman P, Jonkers J.

J Clin Invest. 2016 Aug 1;126(8):2903-18. doi: 10.1172/JCI70196. Epub 2016 Jul 25.

10.

Cost-effectiveness of preventive case management for parents with a mental illness: a randomized controlled trial from three economic perspectives.

Wansink HJ, Drost RMWA, Paulus ATG, Ruwaard D, Hosman CMH, Janssens JMAM, Evers SMAA.

BMC Health Serv Res. 2016 Jul 7;16:228. doi: 10.1186/s12913-016-1498-z.

11.

Omnidirectional beacon-localization using a catadioptric system.

Shen TC, Drost RJ, Sadler BM, Rzasa JR, Davis CC.

Opt Express. 2016 Apr 4;24(7):6931-44. doi: 10.1364/OE.24.006931.

PMID:
27136988
12.

A Web-Based Computer-Tailored Alcohol Prevention Program for Adolescents: Cost-Effectiveness and Intersectoral Costs and Benefits.

Drost RM, Paulus AT, Jander AF, Mercken L, de Vries H, Ruwaard D, Evers SM.

J Med Internet Res. 2016 Apr 21;18(4):e93. doi: 10.2196/jmir.5223.

13.

Patterns of orodental injury and mouthguard use in Dutch field hockey.

Vucic S, Drost RW, van Wijk AJ, Wesselink PR, Wolvius EB.

Br J Sports Med. 2016 Jun;50(11):661-8. doi: 10.1136/bjsports-2015-095677. Epub 2016 Mar 25.

PMID:
27015854
14.

Valuing inter-sectoral costs and benefits of interventions in the healthcare sector: methods for obtaining unit prices.

Drost RM, Paulus AT, Ruwaard D, Evers SM.

Expert Rev Pharmacoecon Outcomes Res. 2017 Feb;17(1):77-84. doi: 10.1586/14737167.2016.1141679. Epub 2016 Feb 12.

PMID:
26757960
15.

Ultra-narrow metallic armchair graphene nanoribbons.

Kimouche A, Ervasti MM, Drost R, Halonen S, Harju A, Joensuu PM, Sainio J, Liljeroth P.

Nat Commun. 2015 Dec 14;6:10177. doi: 10.1038/ncomms10177.

16.

Synthesis of Extended Atomically Perfect Zigzag Graphene - Boron Nitride Interfaces.

Drost R, Kezilebieke S, M Ervasti M, Hämäläinen SK, Schulz F, Harju A, Liljeroth P.

Sci Rep. 2015 Nov 20;5:16741. doi: 10.1038/srep16741.

17.

Dentofacial trauma and players' attitude towards mouthguard use in field hockey: a systematic review and meta-analysis.

Vucic S, Drost RW, Ongkosuwito EM, Wolvius EB.

Br J Sports Med. 2016 Mar;50(5):298-304. doi: 10.1136/bjsports-2015-094896. Epub 2015 Oct 28. Review.

PMID:
26511002
18.

Dead time effects in non-line-of-sight ultraviolet communications.

Drost RJ, Sadler BM, Chen G.

Opt Express. 2015 Jun 15;23(12):15748-61. doi: 10.1364/OE.23.015748.

PMID:
26193553
19.

FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.

Gong C, Fujino K, Monteiro LJ, Gomes AR, Drost R, Davidson-Smith H, Takeda S, Khoo US, Jonkers J, Sproul D, Lam EW.

Oncogene. 2015 Sep 24;34(39):5012-24. doi: 10.1038/onc.2014.421. Epub 2014 Dec 22.

20.

Electronic states at the graphene-hexagonal boron nitride zigzag interface.

Drost R, Uppstu A, Schulz F, Hämäläinen SK, Ervasti M, Harju A, Liljeroth P.

Nano Lett. 2014 Sep 10;14(9):5128-32. doi: 10.1021/nl501895h. Epub 2014 Aug 5.

PMID:
25078791
21.

Design of dual-link (wide- and narrow-beam) LED communication systems.

Shen TC, Drost RJ, Davis CC, Sadler BM.

Opt Express. 2014 May 5;22(9):11107-18. doi: 10.1364/OE.22.011107.

PMID:
24921809
22.

Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme.

Drost RM, Paulus AT, Ruwaard D, Evers SM.

J Ment Health Policy Econ. 2013 Dec;16(4):179-86.

PMID:
24526586
23.

Each of the four intracellular cysteines of CD36 is essential for insulin- or AMP-activated protein kinase-induced CD36 translocation.

van Oort MM, Drost R, Janβen L, Van Doorn JM, Kerver J, Van der Horst DJ, Luiken JJ, Rodenburg KC.

Arch Physiol Biochem. 2014 Feb;120(1):40-9. doi: 10.3109/13813455.2013.876049. Epub 2013 Dec 31.

PMID:
24377880
24.

Ultraviolet scattering propagation modeling: analysis of path loss versus range.

Drost RJ, Moore TJ, Sadler BM.

J Opt Soc Am A Opt Image Sci Vis. 2013 Nov 1;30(11):2259-65. doi: 10.1364/JOSAA.30.002259.

PMID:
24322923
25.

Templated self-assembly and local doping of molecules on epitaxial hexagonal boron nitride.

Schulz F, Drost R, Hämäläinen SK, Liljeroth P.

ACS Nano. 2013 Dec 23;7(12):11121-8. doi: 10.1021/nn404840h. Epub 2013 Oct 25.

PMID:
24152095
26.

A well-defined Pd hybrid material for the Z-selective semihydrogenation of alkynes characterized at the molecular level by DNP SENS.

Conley MP, Drost RM, Baffert M, Gajan D, Elsevier C, Franks WT, Oschkinat H, Veyre L, Zagdoun A, Rossini A, Lelli M, Lesage A, Casano G, Ouari O, Tordo P, Emsley L, Copéret C, Thieuleux C.

Chemistry. 2013 Sep 9;19(37):12234-8. doi: 10.1002/chem.201302484. Epub 2013 Aug 19.

PMID:
23959767
27.

Opportunities and hurdles in the treatment of BRCA1-related breast cancer.

Drost R, Jonkers J.

Oncogene. 2014 Jul 17;33(29):3753-63. doi: 10.1038/onc.2013.329. Epub 2013 Aug 19. Review.

PMID:
23955079
28.

A high-throughput functional complementation assay for classification of BRCA1 missense variants.

Bouwman P, van der Gulden H, van der Heijden I, Drost R, Klijn CN, Prasetyanti P, Pieterse M, Wientjens E, Seibler J, Hogervorst FB, Jonkers J.

Cancer Discov. 2013 Oct;3(10):1142-55. doi: 10.1158/2159-8290.CD-13-0094. Epub 2013 Jul 18.

29.

Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.

Bowman-Colin C, Xia B, Bunting S, Klijn C, Drost R, Bouwman P, Fineman L, Chen X, Culhane AC, Cai H, Rodig SJ, Bronson RT, Jonkers J, Nussenzweig A, Kanellopoulou C, Livingston DM.

Proc Natl Acad Sci U S A. 2013 May 21;110(21):8632-7. doi: 10.1073/pnas.1305362110. Epub 2013 May 8.

30.

Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.

Jaspers JE, Kersbergen A, Boon U, Sol W, van Deemter L, Zander SA, Drost R, Wientjens E, Ji J, Aly A, Doroshow JH, Cranston A, Martin NM, Lau A, O'Connor MJ, Ganesan S, Borst P, Jonkers J, Rottenberg S.

Cancer Discov. 2013 Jan;3(1):68-81. doi: 10.1158/2159-8290.CD-12-0049. Epub 2012 Oct 25.

31.

Mutation screening of 75 candidate genes in 152 complex I deficiency cases identifies pathogenic variants in 16 genes including NDUFB9.

Haack TB, Madignier F, Herzer M, Lamantea E, Danhauser K, Invernizzi F, Koch J, Freitag M, Drost R, Hillier I, Haberberger B, Mayr JA, Ahting U, Tiranti V, Rötig A, Iuso A, Horvath R, Tesarova M, Baric I, Uziel G, Rolinski B, Sperl W, Meitinger T, Zeviani M, Freisinger P, Prokisch H.

J Med Genet. 2012 Feb;49(2):83-9. doi: 10.1136/jmedgenet-2011-100577. Epub 2011 Dec 26.

PMID:
22200994
32.

BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.

Drost R, Bouwman P, Rottenberg S, Boon U, Schut E, Klarenbeek S, Klijn C, van der Heijden I, van der Gulden H, Wientjens E, Pieterse M, Catteau A, Green P, Solomon E, Morris JR, Jonkers J.

Cancer Cell. 2011 Dec 13;20(6):797-809. doi: 10.1016/j.ccr.2011.11.014.

33.

Willingness to pay for a cardiovascular prevention program in highly educated adults: a randomized controlled trial.

Jacobs N, Drost R, Ament A, Evers S, Claes N.

Int J Technol Assess Health Care. 2011 Oct;27(4):283-9. doi: 10.1017/S0266462311000341.

PMID:
22004768
34.

UV communications channel modeling incorporating multiple scattering interactions.

Drost RJ, Moore TJ, Sadler BM.

J Opt Soc Am A Opt Image Sci Vis. 2011 Apr 1;28(4):686-95. doi: 10.1364/JOSAA.28.000686.

PMID:
21478967
35.

Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.

Bouwman P, Drost R, Klijn C, Pieterse M, van der Gulden H, Song JY, Szuhai K, Jonkers J.

J Pathol. 2011 May;224(1):10-21. doi: 10.1002/path.2861. Epub 2011 Mar 14.

PMID:
21404276
36.

Site-Dependent Coordination Bonding in Self-Assembled Metal-Organic Networks.

Henningsen N, Rurali R, Limbach C, Drost R, Pascual JI, Franke KJ.

J Phys Chem Lett. 2011 Jan 20;2(2):55-61. doi: 10.1021/jz1015907. Epub 2010 Dec 21.

PMID:
26295521
37.

Preclinical mouse models for BRCA1-associated breast cancer.

Drost RM, Jonkers J.

Br J Cancer. 2009 Nov 17;101(10):1651-7. doi: 10.1038/sj.bjc.6605350. Epub 2009 Sep 29. Review.

38.

BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.

Puppe J, Drost R, Liu X, Joosse SA, Evers B, Cornelissen-Steijger P, Nederlof P, Yu Q, Jonkers J, van Lohuizen M, Pietersen AM.

Breast Cancer Res. 2009;11(4):R63. doi: 10.1186/bcr2354. Epub 2009 Aug 26.

39.

Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.

Evers B, Drost R, Schut E, de Bruin M, van der Burg E, Derksen PW, Holstege H, Liu X, van Drunen E, Beverloo HB, Smith GC, Martin NM, Lau A, O'Connor MJ, Jonkers J.

Clin Cancer Res. 2008 Jun 15;14(12):3916-25. doi: 10.1158/1078-0432.CCR-07-4953.

40.

Selective hydrogen oxidation in the presence of C3 hydrocarbons using perovskite oxygen reservoirs.

Beckers J, Drost R, van Zandvoort I, Collignon PF, Rothenberg G.

Chemphyschem. 2008 May 16;9(7):1062-8. doi: 10.1002/cphc.200800039.

PMID:
18418824
41.

Factor graph methods for three-dimensional shape reconstruction as applied to LIDAR imaging.

Drost RJ, Singer AC.

J Opt Soc Am A Opt Image Sci Vis. 2004 Oct;21(10):1855-68.

PMID:
15497413
42.

Clinical results with the acoustic puncture assist device, a new acoustic device to identify the epidural space.

Lechner TJ, van Wijk MG, Maas AJ, van Dorsten FR, Drost RA, Langenberg CJ, Teunissen LJ, Cornelissen PH, van Niekerk J.

Anesth Analg. 2003 Apr;96(4):1183-7, table of contents.

PMID:
12651681
43.

DSM-IV internal construct validity: when a taxonomy meets data.

Hartman CA, Hox J, Mellenbergh GJ, Boyle MH, Offord DR, Racine Y, McNamee J, Gadow KD, Sprafkin J, Kelly KL, Nolan EE, Tannock R, Schachar R, Schut H, Postma I, Drost R, Sergeant JA.

J Child Psychol Psychiatry. 2001 Sep;42(6):817-36.

PMID:
11583254
44.

Visualization of flow patterns from stents and stent-grafts in an in vitro flow-model.

Müller-Hülsbeck S, Schwarzenberg H, Wesner F, Drost R, Glüer CC, Heller M.

Invest Radiol. 1998 Oct;33(10):762-70.

PMID:
9788139
45.

Enrichment of G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation by negative selection.

Dreger P, Steinmann J, Drost R, Eckstein V, Suttorp M, Müller-Ruchholtz W, Löffler H, Schmitz N.

Prog Clin Biol Res. 1994;389:407-13. No abstract available.

PMID:
7535449
46.

Pharmacokinetic study of extradural and intrathecal sufentanil anaesthesia for major surgery.

Ionescu TI, Taverne RH, Houweling PL, Drost RH, Nuijten S, Van Rossum J.

Br J Anaesth. 1991 Apr;66(4):458-64.

47.

Pharmacokinetics of flumazenil in fulminant hepatic failure.

van der Rijt CC, Drost RH, Schalm SW, Schramel M.

Eur J Clin Pharmacol. 1991;41(5):501. No abstract available.

PMID:
1761084
48.

Epidural morphine anesthesia for abdominal aortic surgery--pharmacokinetics.

Ionescu TI, Taverne RH, Drost RH, Roelofs JM, Winckers EK, Van Rossum JM.

Reg Anesth. 1989 May-Jun;14(3):107-14. Erratum in: Reg Anesth 1989 Nov-Dec;14(6):307.

PMID:
2486589
49.

Pharmacokinetics of morphine in cerebrospinal fluid and plasma after epidural administration in man.

Drost RH, Ionescu TI, Taverne RH, van Lingen G, van Rossum JM, Maes RA.

Arzneimittelforschung. 1988 Nov;38(11):1632-4.

PMID:
3214449
50.

The pharmacokinetics of intradural morphine in major abdominal surgery.

Ionescu TI, Drost RH, Roelofs JM, Winckers EK, Taverne RH, van Maris AA, van Rossum JM.

Clin Pharmacokinet. 1988 Mar;14(3):178-86.

PMID:
3370903

Supplemental Content

Support Center